Single Patient Safety Concern Hits Allogene’s Off-The-Shelf CAR-T

All Of Company’s Trials Halted

 
• By Andrew McConaghie
  
Allogene building
The first autologous CAR-Ts gained approval in 2017, but the wait for the first allogeneic version goes on.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip